“여탑 ┌ yeotop3 ¸ com석수동오피✴석수동건마⋰석수동스파✍석수동마사지➛석수동오피✌석수동안마➳석수동출장”的搜索结果，显示 171-180 项，共有 16774 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to extend the follow up on the BEAUTY study (MC1137) cohort and collect additional blood samples to evaluate for minimal ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

6. 神经外科- 临床试验- 妙佑医疗国际

   了解神经外科医生如何使用清醒脑部手术和微创脊柱手术等先进技术帮助复杂疾病患者。

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The aim of this study is to create a patient and patient-advocate catalyzed tumor bank for the retrieval, processing, analysis, and maintenance of ...